|Age:||18 to 70 years old|
|Keywords:||glioblastoma, autologous cancer therapy, autologous immunotherapy|
|Type:||Biological study, Phase 2|
The study team will make sure you qualify to take part in the study. Qualified participants will receive detailed information about the study. This may include a list of study-related tests and procedures.